ZVRA - ZEVRA THERAPEUTICS, INC.

QQQ $ 474.86 $ 2.12 (0.45 %)

DIA $ 414.87 $ 2.97 (0.72 %)

SPY $ 561.82 $ 2.92 (0.52 %)

TLT $ 100.40 $ 0.27 (0.27 %)

GLD $ 238.66 $ 2.35 (0.99 %)

Previous Close

$ 7.85

Open

$ 7.77

Bid

$ 7.83 x 100

Ask

-- x --

Day's Range

$ 7.76 - $ 8.10

52 Week Range

$ 3.89 - $ 8.44

Volume

775,972

Average Volume

Market Cap

413.05M

Beta (5Y Monthly)

$ 3.41

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	04-01-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-07-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-12-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-30-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-13-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-12-2021	12-31-2020	10-K
16	10-30-2020	09-30-2020	10-Q
17	08-12-2020	06-30-2020	10-Q
18	05-13-2020	03-31-2020	10-Q
19	02-28-2020	12-31-2019	10-K
20	11-14-2019	09-30-2019	10-Q
21	08-13-2019	06-30-2019	10-Q
22	05-14-2019	03-31-2019	10-Q
23	03-01-2019	12-31-2018	10-K
24	11-09-2018	09-30-2018	10-Q
25	08-10-2018	06-30-2018	10-Q
26	05-11-2018	03-31-2018	10-Q
27	03-30-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-10-2017	06-30-2017	10-Q
30	05-22-2017	03-31-2017	10-Q
31	03-10-2017	12-31-2016	10-K
32	11-10-2016	09-30-2016	10-Q
33	08-11-2016	06-30-2016	10-Q
34	05-13-2016	03-31-2016	10-Q
35	03-16-2016	12-31-2015	10-K
36	11-13-2015	09-30-2015	10-Q
37	08-14-2015	06-30-2015	10-Q
38	05-29-2015	03-31-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Zevra Therapeutics Presents Five Posters A...
09/06/2024 12:32:10

why-nikola-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Nikola Shares Are Trading Lower By Aro...
08/19/2024 17:37:46

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
08/15/2024 17:35:23

Cantor Fitzgerald Reiterates Overweight on...
08/14/2024 13:03:28

Cantor Fitzgerald analyst Louise Chen reiterates Zevra Therapeutics (NASDAQ:ZVRA) with a Overweight.

Zevra Therapeutics Mixed Q2 Results: Details
08/13/2024 21:25:07

Zevra Therapeutics reported its second-quarter financial results Tuesday. Here's a look at the details.

Zevra Therapeutics Q2 2024 GAAP EPS $(0.48...
08/13/2024 20:12:13

Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of ...

pubmatic-eventbrite-five9-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

PubMatic, Eventbrite, Five9 And Other Big ...
08/09/2024 10:44:25

Zevra Therapeutics Prices $60M Public Offe...
08/09/2024 05:12:02

The offering is expected to close on August 12, 2024, subject to customary closing conditions.

Zevra Therapeutics Announces Proposed Publ...
08/08/2024 21:05:24

Zevra Therapeutics, Inc. (NASDAQ:ZVRA), a rare disease therapeutics company ("Zevra"), today announced the commencement...

Cantor Fitzgerald Reiterates Overweight on...
08/05/2024 13:48:19

Cantor Fitzgerald analyst Louise Chen reiterates Zevra Therapeutics (NASDAQ:ZVRA) with a Overweight.

why-kellanova-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket

Why Kellanova Shares Are Trading Higher By...
08/05/2024 12:54:32

fda-panel-backs-zevras-arimoclomol-for-rare-genetic-disorder-analyst-highlights-balanced-portfolio-of-marketed-products-and-pipeline-assets-focused-on-rare-diseases

FDA Panel Backs Zevra's Arimoclomol For Ra...
08/05/2024 11:59:26

FDA panel supports Zevra Therapeutics' arimoclomol for Niemann-Pick disease type C with an 11-5 vote. William Blair boosts ...

HC Wainwright & Co. Maintains Buy on Zevra...
08/05/2024 10:41:08

HC Wainwright & Co. analyst Oren Livnat maintains Zevra Therapeutics (NASDAQ:ZVRA) with a Buy and raises the price targe...

Reported Friday, Zevra Therapeutics Gains ...
08/05/2024 06:27:59

"We are extremely pleased with the committee's recognition of the benefits of arimoclomol for people living with NPC,&#...

Trading Halt: Halt status updated at 6:15:...
08/02/2024 22:15:05

Trading Halt: Halted at 6:55:00 a.m. ET - ...
08/02/2024 10:55:04

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
07/23/2024 17:35:23

insiders-buying-zevra-therapeutics-and-1-other-stock

Insiders Buying Zevra Therapeutics And 1 O...
07/18/2024 10:58:20

insiders-buying-barnes--noble-education-and-2-other-stocks

Insiders Buying Barnes & Noble Education A...
07/17/2024 13:08:14

fda-convenes-expert-panel-meeting-for-zevra-therapeutics-arimoclomol-analyst-optimistic-about-approval-despite-small-patient-base

FDA Convenes Expert Panel Meeting For Zevr...
07/09/2024 19:27:21

FDA's Genetic Metabolic Diseases Advisory Committee will review Zevra Therapeutics' arimoclomol for Niemann-Pick diseas...